807
Participants
Start Date
July 26, 2023
Primary Completion Date
May 30, 2025
Study Completion Date
May 30, 2025
mRNA-1975
Dispersion delivered IM
mRNA-1982
Dispersion delivered IM
Placebo
Solution delivered IM
Rochester Clinical Research, Inc., Rochester
Hatboro Medical Associates/CCT Research, Hatboro
Advanced Primary and Geriatric Care, Rockville
Centennial Medical Group, Columbia
Charlottesville Medical Research Center, LLC, Charlottesville
Clinical Research Atlanta, headlands LLC, Stockbridge
Encore Research Group-Jacksonville Center for Clinical Research, Jacksonville
University Clinical Research-DeLand, LLC d/b/a Accel Research Sites, Lake Mary
Clinical Research Institute, Inc., Minneapolis
Johnson County Clin-Trials, Inc. (JCCT), Lenexa
Meridian Clinical Research - Omaha, Omaha
Lynn Health Science Institute, Oklahoma City
Benchmark Research, Fort Worth
DM Clinical Research, Tomball
Clinical Research Consulting, LLC, Milford
Stamford Therapeutics Consortium, Stamford
Chase Medical Research, LLC, Waterbury
DM Clinical Research - Brookline, Brookline
ActivMed Research LLC, Newington
Velocity Clinical Research Providence, Providence
ModernaTX, Inc.
INDUSTRY